Help Stop Funding Cuts to Medical Research
February 22, 2013 – Funding for the National Institutes of Health (NIH) is in serious jeopardy. Without congressional action, NIH will receive a $1.6 billion cut when sequestration begins on Friday,...
View ArticleApril 8 Rally for Medical Research
April 3, 2013 – Over 150 national organizations and institutions will hold a Rally for Medical Research in Washington, D.C. on April 8. at 11:00 a.m.The purpose of the Rally is to publicly express...
View ArticleJournal Publishes Exjade Food Study Results
April 30, 2013 – The medical journal Pediatric Blood and Cancer published online on April 23 a study entitled “The Palatability and Tolerability of Deferasirox Taken With Different Beverages or Food.”...
View ArticleCAF Funds $375,000 in Important Thalassemia Research Areas
July 15, 2013 – What would motivate a person with thalassemia to make changes to improve adherence to therapy? Can metabolic substances in a person with thalassemia give a clue to how iron is loading...
View ArticleCAF Awards $100,000 in Medical Research Fellowships
CAF is pleased to announce one new Cooley’s Anemia Foundation Medical Research Fellowship and one renewal Fellowship have been awarded for the 2022-2023 grant cycle. The total amount of funding for the...
View ArticleEleventh Cooley’s Symposium Will Take Place on Oct. 17-20 in NYC
The Eleventh Cooley’s Anemia Symposium will bring together basic scientists, clinical investigators, and clinicians to review and discuss recent research for thalassemia syndromes. The post Eleventh...
View ArticleCAF Accepting Applications for 2023 Medical Research Grants & Fellowships
The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia. The post CAF Accepting Applications for 2023 Medical Research...
View ArticleCAF Awards $200,000 in Medical Research Fellowships
We’re proud to announce two new Cooley’s Anemia Foundation Medical Research Fellowships and two renewal Medical Research Fellowships for the 2023-2024 grant cycle. The total amount of funding for the...
View ArticleFDA Approves Vertex & CRISPR’s Gene Editing Therapy to treat Beta Thalassemia
The FDA has approved Vertex and CRISPR’s gene-editing therapy Casgevy to treat beta thalassemia. Casgevy becomes the first therapy for the rare blood disorder to use the innovative CRISPR gene-editing...
View ArticleThalassemia Care Walk 2024 – Register Now!
Care Walk is the Cooley’s Anemia Foundation’s annual fundraising event and opportunity to bring together the thalassemia community and its supporters around the country. Funds raised support medical...
View Article
